101 related articles for article (PubMed ID: 17271050)
1. Systemic virus dissemination during local gene delivery in solid tumors and its control with an alginate solution.
Wang Y; Li CY; Yuan F
Conf Proc IEEE Eng Med Biol Soc; 2004; 2004():3524-6. PubMed ID: 17271050
[TBL] [Abstract][Full Text] [Related]
2. Systemic dissemination of viral vectors during intratumoral injection.
Wang Y; Hu JK; Krol A; Li YP; Li CY; Yuan F
Mol Cancer Ther; 2003 Nov; 2(11):1233-42. PubMed ID: 14617797
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of systemic dissemination of nonreplicating adenoviral vectors from tumours in local gene delivery.
Wang Y; Yang Z; Liu S; Kon T; Krol A; Li CY; Yuan F
Br J Cancer; 2005 Apr; 92(8):1414-20. PubMed ID: 15812558
[TBL] [Abstract][Full Text] [Related]
4. Effects of rate, volume, and dose of intratumoral infusion on virus dissemination in local gene delivery.
Wang Y; Wang H; Li CY; Yuan F
Mol Cancer Ther; 2006 Feb; 5(2):362-6. PubMed ID: 16505110
[TBL] [Abstract][Full Text] [Related]
5. A novel method for viral gene delivery in solid tumors.
Wang Y; Liu S; Li CY; Yuan F
Cancer Res; 2005 Sep; 65(17):7541-5. PubMed ID: 16140915
[TBL] [Abstract][Full Text] [Related]
6. Viral vector delivery in solid-state vehicles: gene expression in a murine prostate cancer model.
Siemens DR; Austin JC; Hedican SP; Tartaglia J; Ratliff TL
J Natl Cancer Inst; 2000 Mar; 92(5):403-12. PubMed ID: 10699070
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral spread of wild-type adenovirus is limited after local injection of human xenograft tumors: virus persists and spreads systemically at late time points.
Sauthoff H; Hu J; Maca C; Goldman M; Heitner S; Yee H; Pipiya T; Rom WN; Hay JG
Hum Gene Ther; 2003 Mar; 14(5):425-33. PubMed ID: 12691608
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus vector-mediated gene transfer to regional lymph nodes.
Labow D; Lee S; Ginsberg RJ; Crystal RG; Korst RJ
Hum Gene Ther; 2000 Mar; 11(5):759-69. PubMed ID: 10757355
[TBL] [Abstract][Full Text] [Related]
10. Tumor-specific gene delivery using recombinant vaccinia virus in a rabbit model of liver metastases.
Gnant MF; Noll LA; Irvine KR; Puhlmann M; Terrill RE; Alexander HR; Bartlett DL
J Natl Cancer Inst; 1999 Oct; 91(20):1744-50. PubMed ID: 10528025
[TBL] [Abstract][Full Text] [Related]
11. In vivo murine tumor gene delivery and expression by systemic recombinant vaccinia virus encoding interleukin-1beta.
Peplinski GR; Tsung AK; Casey MJ; Meko JB; Fredrickson TN; Buller RM; Norton JA
Cancer J Sci Am; 1996; 2(1):21-7. PubMed ID: 9166494
[TBL] [Abstract][Full Text] [Related]
12. Midkine promoter-based adenoviral suicide gene therapy to midkine-positive pediatric tumor.
Adachi Y; Matsubara S; Muramatsu T; Curiel DT; Reynolds PN
J Pediatr Surg; 2002 Apr; 37(4):588-92. PubMed ID: 11912516
[TBL] [Abstract][Full Text] [Related]
13. Delivery of viral vectors to tumor cells: extracellular transport, systemic distribution, and strategies for improvement.
Wang Y; Yuan F
Ann Biomed Eng; 2006 Jan; 34(1):114-27. PubMed ID: 16520902
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumors.
Addison CL; Bramson JL; Hitt MM; Muller WJ; Gauldie J; Graham FL
Gene Ther; 1998 Oct; 5(10):1400-9. PubMed ID: 9930346
[TBL] [Abstract][Full Text] [Related]
15. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo.
Tjuvajev JG; Chen SH; Joshi A; Joshi R; Guo ZS; Balatoni J; Ballon D; Koutcher J; Finn R; Woo SL; Blasberg RG
Cancer Res; 1999 Oct; 59(20):5186-93. PubMed ID: 10537296
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of radiotherapy by hyperthermia-regulated gene therapy.
Lohr F; Hu K; Huang Q; Zhang L; Samulski TV; Dewhirst MW; Li CY
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1513-8. PubMed ID: 11121657
[TBL] [Abstract][Full Text] [Related]
17. Tumor-targeted gene transfer in vivo via recombinant Newcastle disease virus modified by a bispecific fusion protein.
Bian H; Fournier P; Peeters B; Schirrmacher V
Int J Oncol; 2005 Aug; 27(2):377-84. PubMed ID: 16010418
[TBL] [Abstract][Full Text] [Related]
18. Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination.
Bramson JL; Hitt M; Gauldie J; Graham FL
Gene Ther; 1997 Oct; 4(10):1069-76. PubMed ID: 9415313
[TBL] [Abstract][Full Text] [Related]
19. Local high-capacity adenovirus-mediated mCTLA4Ig and mCD40Ig expression prolongs recombinant gene expression in skeletal muscle.
Jiang ZL; Reay D; Kreppel F; Gambotto A; Feingold E; Kochanek S; McCarthy SA; Clemens PR
Mol Ther; 2001 Jun; 3(6):892-900. PubMed ID: 11407903
[TBL] [Abstract][Full Text] [Related]
20. Impact of preimmunization on adenoviral vector expression and toxicity in a subcutaneous mouse cancer model.
Vlachaki MT; Hernandez-Garcia A; Ittmann M; Chhikara M; Aguilar LK; Zhu X; Teh BS; Butler EB; Woo S; Thompson TC; Barrera-Saldana H; Aguilar-Cordova E
Mol Ther; 2002 Sep; 6(3):342-8. PubMed ID: 12231170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
